She directs a team of more than 15 scientists and 10 postgraduate students who work in the field of HIV and SARS-CoV-2 vaccine discovery, combining Virology, Immunology and Bioinformatics. Her research is funded by the NIH, the South African Medical Research Council, the International AIDS Vaccine Initiative, the SA National Research Foundation and the Bill and Melinda Gates Foundation. In the past 20 years, she has contributed towards more than 150 papers, focusing predominantly on HIV and SARS-CoV-2 neutralizing antibodies and their interplay with the evolving virus, a result of extensive collaborations within South Africa and internationally. She holds a NRF B1 rating and has a very strong focus on mentorship and capacity development and supervises several postgraduate students and post-doctoral fellows within her lab and across other institutes.